Kennametal Inc: Form 10-Q for the period ended Dec 31, 2025
Filed with the SEC on Feb 4, 2026 and accepted by EDGAR at Feb 4, 2026, 13:50 ET.
Management's discussion and analysis
As filed, 5,067 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
OVERVIEW
Kennametal Inc. was founded based on a tungsten carbide technology breakthrough in 1938. The Company was incorporated in Pennsylvania in 1943 as a manufacturer of tungsten carbide metal cutting tooling and was listed on the New York Stock Exchange (NYSE) in 1967. With more than 85 years of materials expertise, the Company is a global industrial technology leader, helping customers across the Aerospace & Defense, Earthworks, Energy, General Engineering and Transportation industries manufacture with precision and efficiency. This expertise includes the development and application of tungsten carbides, ceramics, super-hard materials and solutions used in metal cutting and extreme wear applications to keep customers up and running longer against conditions such as corrosion and high temperatures.
Our standard and custom product offering spans metal cutting and wear applications including turning, milling, hole making, tooling systems and services, as well as specialized wear components and metallurgical powders. End users of the Company's metal cutting products include manufacturers engaged in a diverse array of industries including: the manufacturers of transportation vehicles and components, machine tools and light and heavy machinery; airframe and aerospace components; and energy-related components for the oil and gas industry, as well as power generation. The Company’s wear and metallurgical powders are used by producers and suppliers in equipment-intensive operations such as road construction, mining, quarrying, oil and gas exploration, refining, production and supply, and for aerospace and defense.
Throughout MD&A, we refer to measures used by management to evaluate performance. We also refer to a number of financial measures that are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP), including organic sales growth (decline), constant currency regional sales growth (decline) and constant currency end market sales growth (decline). We provide the definitions of these non-GAAP financial measures at the end of the MD&A section as well as details on the use and derivation of these financial measures.
Our sales of $529.5 million for the three months ended December 31, 2025 increased 10 percent from $482.1 million in the prior year quarter, reflecting organic sales growth of 10 percent and a favorable currency exchange effect of 1 percent, partially offset by a divestiture effect of 1 percent.
Operating income for the three months ended December 31, 2025 was $52.7 million compared to $31.7 million in the prior year quarter. The year-over-year increase of $21.0 million was driven by the favorable timing of pricing compared to raw material costs of approximately $17 million within the Infrastructure segment, pricing and tariff surcharges within the Metal Cutting segment, higher sales and production volumes in Metal Cutting, and incremental year-over-year restructuring savings of approximately $8 million. These factors were partially offset by higher compensation costs, tariffs and general inflation, a prior year benefit from insurance proceeds of approximately $3 million that did not repeat in the current year and an increase in incremental restructuring and related charges of approximately $2 million.
Operating margin for the three months ended December 31, 2025 was 9.9 percent compared to 6.6 percent in the prior year quarter. The Metal Cutting and Infrastructure segments had operating margins of 9.0 percent and 11.8 percent, respectively, for the three months ended December 31, 2025.
Uncertainties with respect to evolving global trade policies and tariffs have negatively affected the global economy. The Company's results of operations, cash flows and financial condition could be negatively impacted by a decrease in demand for our products or an inability to effectively mitigate tariff-related cost increases through pricing and sourcing strategies. These factors could also increase the potential for future impairment charges, including goodwill and other intangible asset impairments. We have executed tariff mitigation actions including the implementation of surcharges on certain product sales and, where appropriate, rerouted internal supply chains. The unmitigated net effect from increased tariffs was immaterial during the three months ended December 31, 2025.
Additionally, our business has been negatively affected by foreign currency exchange and inflationary headwinds. We have been able to partially mitigate the effects of inflation, foreign currency exchange challenges and other disruptions through price increases on our products. We cannot predict the ultimate effect of these issues on our business, operating results or financial condition, but we will continue to monitor macroeconomic conditions and attempt to mitigate the negative effect to the extent possible.
For the three months ended December 31, 2025, earnings per diluted share (EPS) was $0.44 compared to EPS of $0.23 in the prior year quarter.
Controls and procedures
As filed, 2,067 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
As of the end of the period covered by this Quarterly Report on Form 10-Q, the Company's management evaluated, with the participation of the Company's Chief Executive Officer and Chief Financial Officer, the effectiveness of the Company's disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)). The Company's disclosure controls were designed to provide a reasonable assurance that information required to be disclosed in reports that we file or submit under the Securities Exchange Act of 1934, as amended (Exchange Act), is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission. It should be noted that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote. However, the controls have been designed to provide reasonable assurance of achieving the controls' stated goals. Based on that evaluation, the Company's Chief Executive Officer and Chief Financial Officer have concluded that the Company's disclosure controls and procedures are effective to provide reasonable assurance at December 31, 2025 that information required to be disclosed in the reports that we file or submit under the Exchange Act is (i) accumulated and communicated to management, including the Company's Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure and (ii) recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission.
There were no changes in the Company's internal control over financial reporting that occurred during the Company's most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-10-01 to 2025-12-31 | $529.5m | us-gaap:Revenues |
| Revenue | 6 months2025-07-01 to 2025-12-31 | $1.03bn | us-gaap:Revenues |
| Cost of revenue | 3 months2025-10-01 to 2025-12-31 | $355.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2025-07-01 to 2025-12-31 | $699.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2025-10-01 to 2025-12-31 | $173.9m | us-gaap:GrossProfit |
| Gross profit | 6 months2025-07-01 to 2025-12-31 | $328.4m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2025-10-01 to 2025-12-31 | $116.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2025-07-01 to 2025-12-31 | $229.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-10-01 to 2025-12-31 | $52.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2025-07-01 to 2025-12-31 | $90.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-10-01 to 2025-12-31 | $6.1m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 6 months2025-07-01 to 2025-12-31 | $12.3m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2025-10-01 to 2025-12-31 | $13.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2025-07-01 to 2025-12-31 | $22.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-10-01 to 2025-12-31 | $33.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months2025-07-01 to 2025-12-31 | $57.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-10-01 to 2025-12-31 | $0.44 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2025-07-01 to 2025-12-31 | $0.74 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-10-01 to 2025-12-31 | $0.44 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2025-07-01 to 2025-12-31 | $0.75 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-10-01 to 2025-12-31 | 77,083,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2025-07-01 to 2025-12-31 | 76,919,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2025-07-01 to 2025-12-31 | $72.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2025-10-01 to 2025-12-31 | $12.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 6 months2025-07-01 to 2025-12-31 | $35.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2025-07-01 to 2025-12-31 | $30.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2025-07-01 to 2025-12-31 | $10.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-12-31 | $129.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-12-31 | $1.12bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $2.60bn | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $439.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $1.24bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-12-31 | $1.32bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-26-005371. Last ingested by Listed: Oct 29, 2026, 10:20 ET. Listed shows no prices and gives no investment advice.